BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas. Vox Sang. 2006;91:1-12. [PMID: 16756595 DOI: 10.1111/j.1423-0410.2006.00773.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Hong SG, Kim JH, Lee YS, Yoon E, Lee HJ, Hwang JK, Jung ES, Joo MK, Jung YK, Yeon JE. The relationship between hepatitis B virus infection and the incidence of pancreatic cancer: a retrospective case-control study. Korean J Hepatol. 2010;16:49-56. [PMID: 20375642 DOI: 10.3350/kjhep.2010.16.1.49] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
2 Laperche S, Maniez M, Barlet V, El Ghouzzi M, Le Vacon F, Levayer T, Lunel F, Morel P, Mouillot L, Piquet Y, Pillonel J. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases. Transfusion 2008;48:2308-14. [DOI: 10.1111/j.1537-2995.2008.01873.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
3 Niederhauser C. Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med 2011;2:91-102. [PMID: 22287868 DOI: 10.2147/JBM.S12899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
4 Antar W, El-Shokry MH, Abd El Hamid WA, Helmy MF. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg. Transfus Med. 2010;20:409-413. [PMID: 20573069 DOI: 10.1111/j.1365-3148.2010.01021.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
5 Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion 2007;47:1794-802. [PMID: 17880603 DOI: 10.1111/j.1537-2995.2007.01394.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
6 Raimondo G, Allain J, Brunetto MR, Buendia M, Chen D, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky J, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F. Statements from the Taormina expert meeting on occult hepatitis B virus infection. Journal of Hepatology 2008;49:652-7. [DOI: 10.1016/j.jhep.2008.07.014] [Cited by in Crossref: 513] [Cited by in F6Publishing: 484] [Article Influence: 39.5] [Reference Citation Analysis]
7 Yang MH, Li L, Hung YS, Hung CS, Allain JP, Lin KS, Tsai SJ. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion. 2010;50:65-74. [PMID: 19709394 DOI: 10.1111/j.1537-2995.2009.02357.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
8 Linauts S, Saldanha J, Strong DM. PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples. Transfusion. 2008;48:1376-1382. [PMID: 18422847 DOI: 10.1111/j.1537-2995.2008.01698.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
9 Dodd RY. Current risk for transfusion transmitted infections. Curr Opin Hematol 2007;14:671-6. [PMID: 17898573 DOI: 10.1097/MOH.0b013e3282e38e8a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 23] [Article Influence: 0.1] [Reference Citation Analysis]
10 Beltrán M, Berrío-pérez M, Bermúdez MI, Rey-benito G, Camacho B, Forero P, Molina GC, Fals O, Pisciotti I, Oliveros Y, Cortés A, De La Hoz F. Detección de hepatitis B oculta en donantes de bancos sangre, Colombia 2008-2009. biomedica 2011;31:580. [DOI: 10.7705/biomedica.v31i4.446] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med. 2010;48:23-29. [PMID: 19919328 DOI: 10.1515/cclm.2010.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
12 Ba Alawi F, Robertson PW, LePage AK, Jayamaha J, Baleriola C, Rawlinson WD. The reliability of HBV core antibody in serological screening for hepatitis B virus. Pathology 2013;45:501-5. [PMID: 23842045 DOI: 10.1097/PAT.0b013e3283631cf9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
13 O'brien SF, Yi Q, Fan W, Fearon MA, Scalia V, Goldman M. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay. Transfusion 2009;49:271-7. [DOI: 10.1111/j.1537-2995.2008.01973.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
14 Louisirirotchanakul S, Oota S, Khuponsarb K, Chalermchan W, Phikulsod S, Chongkolwatana V, Sakuldamrongpanish T, Kitpoka P, Chielsilp P, Tanprasert S, Tirawatnapong T, Wasi C; Working Group for NAT Study in Thai Blood Donations. Occult hepatitis B virus infection in Thai blood donors. Transfusion 2011;51:1532-40. [PMID: 21251005 DOI: 10.1111/j.1537-2995.2010.03023.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
15 Stolz M, Tinguely C, Graziani M, Fontana S, Gowland P, Buser A, Michel M, Canellini G, Züger M, Schumacher P, Lelie N, Niederhauser C. Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region. Transfusion 2010;50:2695-706. [PMID: 20573074 DOI: 10.1111/j.1537-2995.2010.02732.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
16 Kleinman SH, Lelie N, Busch MP. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion. 2009;49:2454-2489. [PMID: 19682345 DOI: 10.1111/j.1537-2995.2009.02322.x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 138] [Article Influence: 12.9] [Reference Citation Analysis]
17 Bouike Y, Imoto S, Mabuchi O, Kokubunji A, Kai S, Okada M, Taniguchi R, Momose S, Uchida S, Nishio H. Infectivity of HBV DNA positive donations identified in look-back studies in Hyogo-Prefecture, Japan. Transfus Med. 2011;21:107-115. [PMID: 21118317 DOI: 10.1111/j.1365-3148.2010.01057.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
18 Niazi SK, Bhatti FA, Salamat N, Ghani E, Tayyab M. Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan. Transfusion 2015;55:1803-11. [PMID: 25648663 DOI: 10.1111/trf.13017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
19 Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong Y, Nichols D, Ziermann R, Ness P, Nelson KE. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand: MULTIPLEX NAT SCREENING IN THAILAND. Transfusion 2007;47:1803-8. [DOI: 10.1111/j.1537-2995.2007.01395.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
20 María García-montalvo B, Patricia Ventura-zapata L. Molecular and serological characterization of occult hepatitis B infection in blood donors from Mexico. Annals of Hepatology 2011;10:133-41. [DOI: 10.1016/s1665-2681(19)31561-3] [Cited by in Crossref: 14] [Article Influence: 1.4] [Reference Citation Analysis]
21 Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion. 2008;48:2205-2213. [PMID: 18631163 DOI: 10.1111/j.1537-2995.2008.01813.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
22 Adouani B, Alami R, Laouina A, Benahadi A, Boulahdid S, Mokhtari A, Soulaymani A, Abouyoub A, Benajiba M. Hepatitis B in Moroccan blood donors: a decade trend of the HBsAg prevalence in a resources limited country. Transfus Med 2013;23:432-7. [PMID: 23841654 DOI: 10.1111/tme.12054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Phikulsod S, Oota S, Tirawatnapong T, Sakuldamrongpanich T, Chalermchan W, Louisirirotchanakul S, Tanprasert S, Chongkolwatana V, Kitpoka P, Phanuphak P, Wasi C, Nuchprayoon C; Working Group for NAT Study in Thai Blood Donations. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 2009;49:1126-35. [PMID: 19392770 DOI: 10.1111/j.1537-2995.2009.02176.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
24 Tsoi WC, Lelie N, Lin CK. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay. Transfusion 2013;53:2477-88. [PMID: 23521050 DOI: 10.1111/trf.12165] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
25 Candotti D, Allain JP. Transfusion-transmitted hepatitis B virus infection. J Hepatol. 2009;51:798-809. [PMID: 19615780 DOI: 10.1016/j.jhep.2009.05.020] [Cited by in Crossref: 115] [Cited by in F6Publishing: 114] [Article Influence: 9.6] [Reference Citation Analysis]
26 Zobeiri M. Occult hepatitis B: clinical viewpoint and management. Hepat Res Treat. 2013;2013:259148. [PMID: 23533738 DOI: 10.1155/2013/259148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
27 Khamesipour A, Amiri ZM, Kafiabad SA, Saadat F, Mansour-ghanaei F, Esteghamati AR, Shakib RJ. Frequency of hepatitis B virus DNA in anti-HBc positive, HBsAg negative blood donors in Rasht, northern Iran. Transfus Apher Sci 2011;45:195-7. [PMID: 21971311 DOI: 10.1016/j.transci.2011.08.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
28 Seed CR. Value of retaining HBsAg donor screening where HBV NAT and anti-HBc donor screening apply. VOXS 2018;13:70-5. [DOI: 10.1111/voxs.12368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
29 Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis. 2008;46:868-875. [PMID: 18269332 DOI: 10.1086/528687] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 4.2] [Reference Citation Analysis]
30 Chigurupati P, Murthy KS. Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety. Asian J Transfus Sci 2015;9:9-11. [PMID: 25722565 DOI: 10.4103/0973-6247.150938] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
31 Yang L, Song LW, Fang LL, Wu Y, Ge SX, Li H, Yuan Q, Zhang J, Xia NS. Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection. J Virol Methods 2016;228:55-9. [PMID: 26615806 DOI: 10.1016/j.jviromet.2015.11.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
32 Margaritis AR, Brown SM, Seed CR, Kiely P, D’Agostino B, Keller AJ. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion. 2007;47:1783-1793. [PMID: 17880602 DOI: 10.1111/j.1537-2995.2007.01343.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
33 Candotti D, Allain JP. Molecular virology in transfusion medicine laboratory. Blood Transfus. 2013;11:203-216. [PMID: 23356973 DOI: 10.2450/2012.0219-12] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
34 Dhawan HK, Marwaha N, Sharma RR, Chawla Y, Thakral B, Saluja K, Sharma SK, Thakur MK, Jain A. Anti-HBc screening in Indian blood donors: still an unresolved issue. World J Gastroenterol 2008;14:5327-30. [PMID: 18785287 DOI: 10.3748/wjg.14.5327] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
35 Juhl D, Luhm J, Görg S, Ziemann M, Hennig H. Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen: ANTI-HBc TESTING OF BLOOD DONORS. Transfusion 2011;51:1477-85. [DOI: 10.1111/j.1537-2995.2010.03031.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
36 Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730-3733. [PMID: 17659734 DOI: 10.3748/wjg.v13.i27.3730] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
37 Kafi-abad SA, Rezvan H, Abolghasemi H. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007. Transfus Med 2009;19:189-94. [PMID: 19708860 DOI: 10.1111/j.1365-3148.2009.00935.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
38 Zou S, Stramer SL, Notari EP, Kuhns MC, Krysztof D, Musavi F, Fang CT, Dodd RY. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion. 2009;49:1609-1620. [PMID: 19413732 DOI: 10.1111/j.1537-2995.2009.02195.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 8.8] [Reference Citation Analysis]
39 Amer F, Yousif MM, Mohtady H, Khattab RA, Karagoz E, Ayaz KFM, Hammad NM. Surveillance and impact of occult hepatitis B virus, SEN virus, and torque teno virus in Egyptian hemodialysis patients with chronic hepatitis C virus infection. Int J Infect Dis 2020;92:13-8. [PMID: 31863879 DOI: 10.1016/j.ijid.2019.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kim MJ, Park Q, Min HK, Kim HO. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010. BMC Infect Dis. 2012;12:160. [PMID: 22817275 DOI: 10.1186/1471-2334-12-160] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
41 Charuworn P, Cheung R. Diagnostic markers for hepatitis virus infection. Expert Opinion on Medical Diagnostics 2008;2:303-14. [DOI: 10.1517/17530059.2.3.303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Kleinman S. Blood donor screening with nucleic acid amplification tests for human immunodeficiency virus, hepatitis C virus and hepatitis B virus. ISBT Science Series 2008;3:191-5. [DOI: 10.1111/j.1751-2824.2008.00167.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
43 Moiz B, Moatter T, Shaikh U, Adil S, Ali N, Mahar F, Shamsuddin N, Khurshid M. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan. Transfusion. 2014;54:1652-1659. [PMID: 24383918 DOI: 10.1111/trf.12521] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
44 Roth WK. Hepatitis B and blood transfusion. ISBT Science Series 2007;2:178-83. [DOI: 10.1111/j.1751-2824.2007.00097.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
45 Reich-slotky R, Semidei-pomales M, Schwartz J. Microbial pathogens of hematopoietic stem cells – screening and testing for infectious diseases. Reviews in Medical Microbiology 2007;18:17-27. [DOI: 10.1097/mrm.0b013e3282cdf04a] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
46 Durro V, Qyra S. Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009. Virol J 2011;8:96. [PMID: 21375724 DOI: 10.1186/1743-422X-8-96] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
47 Seem DL, Lee I, Umscheid CA, Kuehnert MJ; United States Public Health Service. PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep 2013;128:247-343. [PMID: 23814319 DOI: 10.1177/003335491312800403] [Cited by in Crossref: 158] [Cited by in F6Publishing: 120] [Article Influence: 19.8] [Reference Citation Analysis]
48 Lim YA, Yoon S. An Experience of the Use of Anti-HBc and Anti-HBs for Blood Donor Screening Tests at a Tertiary Hospital Blood Center in Korea. Ann Lab Med 2009;29:59-65. [DOI: 10.3343/kjlm.2009.29.1.59] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]